Sponsored by Empire State Development’s Division of Science, Technology and Innovation (NYSTAR), the UB Center for Advanced Technology in Big Data and Health Sciences (UB CAT) is one of 15 designated Centers in the state dedicated to leveraging University resources to drive company growth. UB’s CAT is specifically focused on the intersection of big data and health sciences, particularly as it relates to drug development, medical devices, diagnostic tools and healthcare IT.
The UB CAT provides eligible companies with project cost sharing grants to fund industry-university collaborations in big data and health sciences arenas. Through these cost sharing grants, NYS health sciences companies utilizing big data can leverage funding, access to expertise, equipment, and reduced rates on services, and supplies through UB to address challenges and achieve goals on the path to commercialization.
*Matching fund requirement is capped at a ratio $1:$1 for small companies (<100 employees) and $1:$2 for large companies (>100 employees).
** All projects are subject to State University of New York intellectual property policies. Principal Investigator eligibility is dependent on policy guidelines at the University at Buffalo (https://www.buffalo.edu/administrative-services/policy1/ub-policy-lib/principal-investigator-eligibility.html.
*** Economic impact resulting from a project is defined as an increase in company sponsor revenues (federal, non-government, product-based), cost savings to company, new jobs created, jobs saved, capital expenditures by company sponsor, intellectual property development, new company start-up opportunity or company relocation / expansion in New York State. Companies that receive CAT funding are required to provide annual economic impact reports for five years.
Email a UB CAT program expert.
Current UB CAT projects where faculty and industry have partnered in 2018: